Bond Eli Lilly & Company 5% ( US532457CE69 ) in USD

Issuer	Eli Lilly & Company
Market price	99.994 % ▲
Country	United States
ISIN code	US532457CE69 ( in USD )
Interest rate	5% per year ( payment 2 times a year)
Maturity	27/02/2026
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible
Minimal amount	2 000 USD
Total amount	750 000 000 USD
Cusip	532457CE6
Standard & Poor's ( S&P ) rating	A+ ( Upper medium grade - Investment-grade )
Moody's rating	Aa3 ( High grade - Investment-grade )
Next Coupon	27/02/2026 ( In 162 days )
Detailed description	Eli Lilly and Company is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical products and biologicals. This financial analysis details a specific bond issued by Eli Lilly, a prominent pharmaceutical company headquartered in the United States, identified by its ISIN US532457CE69 and CUSIP 532457CE6. The bond, denominated in USD, carries an annual interest rate of 5% and features a total issue size of $750,000,000, with a maturity date of February 27, 2026. Interest payments are made semiannually, and the bond is currently trading at 99.956% of its par value on the market, with a minimum purchase amount set at $2,000. This debt instrument benefits from robust credit ratings, having received an A+ from Standard & Poor's and an Aa3 from Moody's, reflecting Eli Lilly's strong financial standing.